CRISPR in cancer biology and therapy

A Katti, BJ Diaz, CM Caragine, NE Sanjana… - Nature Reviews …, 2022 - nature.com
Over the past decade, CRISPR has become as much a verb as it is an acronym,
transforming biomedical research and providing entirely new approaches for dissecting all …

Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors

AV Anzalone, LW Koblan, DR Liu - Nature biotechnology, 2020 - nature.com
The development of new CRISPR–Cas genome editing tools continues to drive major
advances in the life sciences. Four classes of CRISPR–Cas-derived genome editing agents …

Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors

JL Doman, A Raguram, GA Newby, DR Liu - Nature biotechnology, 2020 - nature.com
Cytosine base editors (CBEs) enable targeted C• G-to-T• A conversions in genomic DNA.
Recent studies report that BE3, the original CBE, induces a low frequency of genome-wide …

Precision genome editing using cytosine and adenine base editors in mammalian cells

TP Huang, GA Newby, DR Liu - Nature protocols, 2021 - nature.com
Genome editing has transformed the life sciences and has exciting prospects for use in
treating genetic diseases. Our laboratory developed base editing to enable precise and …

The design and application of DNA-editing enzymes as base editors

KL Rallapalli, AC Komor - Annual review of biochemistry, 2023 - annualreviews.org
DNA-editing enzymes perform chemical reactions on DNA nucleobases. These reactions
can change the genetic identity of the modified base or modulate gene expression. Interest …

CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells

MG Kluesner, WS Lahr, C Lonetree… - Nature …, 2021 - nature.com
CRISPR-Cas9 cytidine and adenosine base editors (CBEs and ABEs) can disrupt genes
without introducing double-stranded breaks by inactivating splice sites (BE-splice) or by …

Enrichment strategies to enhance genome editing

NS Mikkelsen, RO Bak - Journal of Biomedical Science, 2023 - Springer
Genome editing technologies hold great promise for numerous applications including the
understanding of cellular and disease mechanisms and the development of gene and …

Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A

S Harjes, HM Kurup, AE Rieffer, M Bayarjargal… - Nature …, 2023 - nature.com
The normally antiviral enzyme APOBEC3A is an endogenous mutagen in human cancer. Its
single-stranded DNA C-to-U editing activity results in multiple mutagenic outcomes including …

The current toolbox for APOBEC drug discovery

MJ Grillo, KFM Jones, MA Carpenter, RS Harris… - Trends in …, 2022 - cell.com
Mutational processes driving genome evolution and heterogeneity contribute to immune
evasion and therapy resistance in viral infections and cancer. APOBEC3 (A3) enzymes …

DNA deamination is required for human APOBEC3A-driven hepatocellular carcinoma in vivo

JA Naumann, PP Argyris, MA Carpenter… - International journal of …, 2023 - mdpi.com
Although the APOBEC3 family of single-stranded DNA cytosine deaminases is well-known
for its antiviral factors, these enzymes are rapidly gaining attention as prominent sources of …